Jayne Curry

1.4k total citations
15 papers, 490 citations indexed

About

Jayne Curry is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Jayne Curry has authored 15 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Immunology. Recurrent topics in Jayne Curry's work include Heat shock proteins research (4 papers), Microtubule and mitosis dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Jayne Curry is often cited by papers focused on Heat shock proteins research (4 papers), Microtubule and mitosis dynamics (3 papers) and Acute Myeloid Leukemia Research (2 papers). Jayne Curry collaborates with scholars based in United Kingdom, Belgium and China. Jayne Curry's co-authors include Neil T. Thompson, Nicola G. Wallis, John F. Lyons, Tomoko Smyth, Sebastian Thrun, David Lieb, John R. Rogers, Matthias Reule, Lynsey Fazal and Hayley C. Angove and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jayne Curry

14 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayne Curry United Kingdom 8 291 110 86 73 51 15 490
Shaowu Chen China 10 469 1.6× 238 2.2× 10 0.1× 49 0.7× 124 2.4× 18 816
K. Pavan Kalyan India 4 201 0.7× 186 1.7× 23 0.3× 52 0.7× 39 0.8× 5 449
Jong-Kwang Kim South Korea 12 288 1.0× 61 0.6× 31 0.4× 14 0.2× 18 0.4× 39 590
Leilei Yan China 11 414 1.4× 98 0.9× 11 0.1× 20 0.3× 56 1.1× 28 582
Xiuhui Chen China 15 532 1.8× 54 0.5× 31 0.4× 18 0.2× 7 0.1× 35 914
Shaochuang Wang China 14 288 1.0× 60 0.5× 11 0.1× 41 0.6× 7 0.1× 24 589
R J Locke United Kingdom 6 321 1.1× 121 1.1× 5 0.1× 31 0.4× 114 2.2× 7 587
Verena Becker Germany 12 474 1.6× 189 1.7× 63 0.7× 49 0.7× 7 0.1× 20 789
Aparna Gorthi United States 13 548 1.9× 147 1.3× 96 1.1× 39 0.5× 12 0.2× 23 754
Yuehua Li China 10 349 1.2× 181 1.6× 7 0.1× 17 0.2× 28 0.5× 36 663

Countries citing papers authored by Jayne Curry

Since Specialization
Citations

This map shows the geographic impact of Jayne Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayne Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayne Curry more than expected).

Fields of papers citing papers by Jayne Curry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayne Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayne Curry. The network helps show where Jayne Curry may publish in the future.

Co-authorship network of co-authors of Jayne Curry

This figure shows the co-authorship network connecting the top 25 collaborators of Jayne Curry. A scholar is included among the top collaborators of Jayne Curry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayne Curry. Jayne Curry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chan, Pui Shan, Kwok Wai Lo, Jayne Curry, et al.. (2013). A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. Molecular Cancer. 12(1). 128–128. 53 indexed citations
2.
Smyth, Tomoko, Thomas Van Looy, Jayne Curry, et al.. (2012). The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor Models. Molecular Cancer Therapeutics. 11(8). 1799–1808. 49 indexed citations
3.
Smyth, Tomoko, Jayne Curry, Brent Graham, et al.. (2012). Abstract 2772: AT13387, an HSP90 inhibitor, is effective in both vemurafenib-sensitive and -resistant melanoma models. Cancer Research. 72(8_Supplement). 2772–2772. 1 indexed citations
4.
Graham, Brent, Jayne Curry, Tomoko Smyth, et al.. (2011). The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non‐small cell lung cancer. Cancer Science. 103(3). 522–527. 65 indexed citations
5.
Smyth, Tomoko, Thomas Van Looy, Jayne Curry, et al.. (2011). Abstract A217: The HSP90 inhibitor AT13387 demonstrates potent antitumor activity in both imatinib-sensitive and imatinib-resistant gastrointestinal stromal tumor models.. Molecular Cancer Therapeutics. 10(11_Supplement). A217–A217.
6.
Dawson, Mark A., Jayne Curry, Philip Beer, et al.. (2010). AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. British Journal of Haematology. 150(1). 46–57. 41 indexed citations
7.
Curry, Jayne, Hayley C. Angove, Lynsey Fazal, et al.. (2009). Aurora B kinase inhibition in mitosis: Strategies for optimizing the use of Aurora kinase inhibitors such as AT9283. Cell Cycle. 8(12). 1921–1929. 41 indexed citations
8.
Lyons, John, Jayne Curry, Tomoko Smyth, et al.. (2009). Abstract A217: Comparison of long-term pharmacodynamic actions of the synthetic small molecule HSP90 inhibitor AT13387 in multiple xenograft models. Molecular Cancer Therapeutics. 8(12_Supplement). A217–A217. 2 indexed citations
9.
Howard, Steven, Valério Berdini, Jayne Curry, et al.. (2008). 287 POSTER Fragment-based discovery of AT9283; a multi-targeted kinase inhibitor with potent Aurora kinase activity. European Journal of Cancer Supplements. 6(12). 93–93. 3 indexed citations
10.
Rogers, John R., et al.. (2007). Reverse Optical Flow for Self-Supervised Adaptive Autonomous Robot Navigation. International Journal of Computer Vision. 74(3). 287–302. 64 indexed citations
11.
Squires, Matthew, Jayne Curry, Mark A. Dawson, et al.. (2007). AT9283, a Potent Inhibitor of JAK2, Is Active in JAK2 V617F Myeloproliferative Disease Models.. Blood. 110(11). 3537–3537. 6 indexed citations
12.
Gallagher, Neil J., John F. Lyons, Jayne Curry, et al.. (2006). Characterisation of aurora kinase inhibitors derived from fragment based lead discovery. Cancer Research. 66. 1155–1155. 2 indexed citations
13.
Gill, Adrian L., Martyn Frederickson, Anne Cleasby, et al.. (2004). Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation. Journal of Medicinal Chemistry. 48(2). 414–426. 146 indexed citations
14.
Loudon, Peter T., C. S. McLean, Gilly Martin, et al.. (2003). Preclinical evaluation of DISC‐GMCSF for the treatment of breast carcinoma. The Journal of Gene Medicine. 5(5). 407–416. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026